Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT02009618
Eligibility Criteria:
Inclusion Criteria:
* Patients between the ages of 18 and 50 years without alarm symptoms, who were examined at the Gastroenterology Clinic, without endoscopic assessment, due to complaints of Irritable Bowel Syndrome, and pre-diagnosed with Irritable Bowel Syndrome according to the Rome III criteria, will be included in the study.
Exclusion Criteria:
1. are under the age of 18 years,
2. are allergic to Rifaximin,
3. are pregnant and lactating,
4. have documented diseases of the gastrointestinal system (such as gastric and duodenal ulcers, gastric cancer, small intestine and colon cancer, inflammatory bowel disease \[Crohn's and Ulcerative Colitis\], gastroparesis, chronic intestinal ischemia, etc.),
5. have (describe) documented diseases of the pancreas, biliary tract, and liver (such as pancreatitis, biliary colic pain associated with gallstones, acute cholecystitis, choledochal stone, hepatitis, hepatobiliary cancers, etc.),
6. have previously undergone major abdominal surgery,
7. have a systemic disease (such as collagen tissue disorders, kidney dysfunction, systemic infection, etc.),
8. have an identified psychiatric disorder,
and/or
9. consume alcohol excessively
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT02009618
Study Brief:
Protocol Section:
NCT02009618